Login to Your Account


Facing the Patent Cliff, Pharma Clings to Blockbuster Drugs

By Mari Serebrov
Washington Editor

Tuesday, April 10, 2012

Big pharma is refusing to go quietly into the night as its biggest blockbusters fall off the patent cliff, endangering more than half of some drugmakers' brand portfolios.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription